These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8770510

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.
    Casadevall A, Mukherjee J, Devi SJ, Schneerson R, Robbins JB, Scharff MD.
    J Infect Dis; 1992 Jun; 165(6):1086-93. PubMed ID: 1583327
    [Abstract] [Full Text] [Related]

  • 7. An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan.
    van de Moer A, Salhi SL, Cherniak R, Pau B, Garrigues ML, Bastide JM.
    Res Immunol; 1990 Jan; 141(1):33-42. PubMed ID: 2189167
    [Abstract] [Full Text] [Related]

  • 8. Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide.
    Spiropulu C, Eppard RA, Otteson E, Kozel TR.
    Infect Immun; 1989 Oct; 57(10):3240-2. PubMed ID: 2476401
    [Abstract] [Full Text] [Related]

  • 9. Specificity of Cryptococcus neoformans factor sera determined by enzyme-linked immunosorbent assay and dot enzyme assay.
    Belay T, Cherniak R, Shinoda T.
    Infect Immun; 1993 Jul; 61(7):2879-85. PubMed ID: 7685739
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen.
    Percival A, Thorkildson P, Kozel TR.
    Clin Vaccine Immunol; 2011 Aug; 18(8):1292-6. PubMed ID: 21697342
    [Abstract] [Full Text] [Related]

  • 11. Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay.
    Belay T, Cherniak R, Kozel TR, Casadevall A.
    Infect Immun; 1997 Feb; 65(2):718-28. PubMed ID: 9009335
    [Abstract] [Full Text] [Related]

  • 12. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.
    Belay T, Cherniak R.
    Infect Immun; 1995 May; 63(5):1810-9. PubMed ID: 7537249
    [Abstract] [Full Text] [Related]

  • 13. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.
    Maitta RW, Datta K, Chang Q, Luo RX, Witover B, Subramaniam K, Pirofski LA.
    Infect Immun; 2004 Aug; 72(8):4810-8. PubMed ID: 15271943
    [Abstract] [Full Text] [Related]

  • 14. Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.
    Duro RM, Netski D, Thorkildson P, Kozel TR.
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):252-8. PubMed ID: 12626451
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.
    Todaro-Luck F, Reiss E, Cherniak R, Kaufman L.
    Infect Immun; 1989 Dec; 57(12):3882-7. PubMed ID: 2680986
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Production and characterization of agglutinating monoclonal antibodies against predominant antigenic factors for Candida albicans.
    Miyakawa Y, Kagaya K, Fukazawa Y, Soe G.
    J Clin Microbiol; 1986 May; 23(5):881-6. PubMed ID: 3519660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.